This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Comergent Technologies Inc.: Enterprise E-Commerce, Teaching Note
Rangan, V. Kasturi; Bellfor, MarieTeaching Note HBS-507087-EMarketingTeaching Note to (505-016). An abstract is not available for this product.Starting at €0.00
-
Borregaard Fine Chemicals - BFC
Svendsen J. E.; Nueno, PedroCase P-918-EService and Operations ManagementStarting at €8.20
-
MatCertificate
Benoit, J. E.; Maisonneuve, P.; Nueno, PedroCase E-39-EEntrepreneurshipMatCertificate is a Business Plan. The company wants to be an independent certification agency in the second hand heavy industrial equipment market. By increasing the visibility between the sellers and the buyers dims pretends to improve the efficiency of this market with its services.Starting at €8.20
-
Aquatic Adriatic
Buljan, L.; Goddard, S.; Bruijn, E.; Nueno, PedroCase E-43-EEntrepreneurshipAquatic Adriatic plans to set up and operate a chain of small, different marinas for the leisure sailing market located on the islands of Croatia.Starting at €8.20
-
Borregaard Fine Chemicals - BFC
Svendsen J. E.; Nueno, PedroCase P-918Service and Operations ManagementEl gerente de la división de productos de química fina de una importante compañía noruega se plantea cómo revitalizar la creatividad de su unidad. La división que tuvo éxitos en innovaciones originales en el pasado se ha convertido en una empresa que va a remolque de sus clientes. El gerente entrevista a varios directivos que fueron clave en el pasado tratando de reconstruir lo que aparentemente fue una cultura estimuladora de la innovación....Starting at €8.20
-
Barna Biológica, S.A. (B)
Baxter, E.; Nueno, Pedro; Serra, Fernando; Yragui J.Case P-503-EService and Operations ManagementStarting at €5.74
-
Gilead: Hepatitis-C Access Strategy (A)
Rangan, V. Kasturi; Rangan, Vikram; Bloom, David E.Case HBS-515025-EGilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the disease. The company had earned accolades for its work in HIV/AIDS, where its innovative medicines now accounted for 60% of all patients on Anti-Retroviral (ARV) medicines. Much of thi...Starting at €8.20
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
Barna-Biológica, S.A. (B)
Baxter, E.; Nueno, Pedro; Serra, Fernando; Yragui J.Case P-503Service and Operations ManagementPequeña empresa española en gran crecimiento en el sector de la biotecnología. Se observa todo el proceso de desarrollo y planificación de las innovaciones.Starting at €5.74
-
Kubi Wireless (A)
Ghosh, Anindya; Malaspina, K.; Cassidy, D.; Nueno, PedroCase E-41EntrepreneurshipKubi Wireless pretende ofrecer, mediante tecnología de redes de área local inalámbricas, a quienes viajan por motivos de negocios, acceso inalámbrico a Internet de alta velocidad que resulta práctico, fácil de utilizar y económico, liberando al usuario de conexiones físicas e hilos.Starting at €8.20